Stiftungsprofessur für Neuroimmunologie

Umwidmung / Auflösung: 15.03.2018
Adresse:
Schwabachanlage 6
91054 Erlangen


Publikationen


Haase, S., Haghikia, A., Gold, R., & Linker, R. (2018). Dietary fatty acids and susceptibility to multiple sclerosis. Multiple sclerosis journal, 24(1), 12-16. https://dx.doi.org/10.1177/1352458517737372
Wang, R., Roy, S., de Rojas Leal, C., Liu, M., Hoesl, K., Lee, D.-H.,... Hilz, M.-J. (2018). Reduced pupillary modulation in patients with relapsing-remitting Multiple Sclerosis is associated with longer disease duration and higher disease severity. (pp. 80-80).
Schmidt, M., Linker, R., Lang, S., Lücking, H., Engelhorn, T., Kloska, S.,... Dankerl, P. (2017). FLAIRfusion Processing with Contrast Inversion : Improving Detection and Reading Time of New Cerebral MS Lesions. Clinical Neuroradiology. https://dx.doi.org/10.1007/s00062-017-0567-y
Joerg, S., Grohme, D.A., Erzler, M., Binsfeld, M., Haghikia, A., Mueller, D.N.,... Kleinewietfeld, M. (2016). Environmental factors in autoimmune diseases and their role in multiple sclerosis. Cellular and Molecular Life Sciences, 73(24), 4611-4622. https://dx.doi.org/10.1007/s00018-016-2311-1
Linker, R., & Wendt, G. (2016). Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study. Neurology and Therapy, 5(2), 193-201. https://dx.doi.org/10.1007/s40120-016-0051-7
Domenig, O., Manzel, A., Grobe, N., Koenigshausen, E., Kaltenecker, C.C., Kovarik, J.J.,... Poglitsch, M. (2016). Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Scientific Reports, 6, 33678. https://dx.doi.org/10.1038/srep33678
Binger, K.J., Gebhardt, M., Heinig, M., Rintisch, C., Schröder, A., Neuhofer, W.,... Mueller, D.N. (2015). High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. Journal of Clinical Investigation, 125(11), 4223-38. https://dx.doi.org/10.1172/JCI80919
Binger, K.J., Linker, R., Muller, D.N., & Kleinewietfeld, M. (2015). Sodium chloride, SGK1, and Th17 activation. Pflugers Archiv-European Journal of Physiology, 467(3), 543-50. https://dx.doi.org/10.1007/s00424-014-1659-z
Linker, R. (2015). Zeigen die neuen oralen Therapien Vorteile in der Basistherapie der Multiplen Sklerose? Kontra. Der Nervenarzt, 86(4), 492-4. https://dx.doi.org/10.1007/s00115-014-4246-9

Zuletzt aktualisiert 2019-24-04 um 17:57